Lifecore Biomedical Inc (LFCR) Stock Price, Quote & News

Company Profile

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacture of hyaluronate acid in bulk form; and formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. It also provides product development services include analytical method development and validation, formulation development...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 952 368 4300

Website: www.lifecore.com

Address:

3515 Lyman Boulevard, Chaska, United States

11thestate Jan. 16 at 2:42 PM

$LFCR is now accepting claims for a settlement it is paying to investors over claims that it misled investors about financial controls and business prospects. If you bought $LFCR between October 7, 2020 and March 19, 2024, you still can file for payment here: https://11th.com/cases/lifecore-investor-settlement

0 · Reply

BearTamerTrading Jan. 11 at 11:57 PM

On Watch for JPM Week: Part 2 $MLAB – Mesa Labs – will present on Jan 14, 2026. $AAPG – Ascentage Pharma Group International – announced presentation. $LFCR – Lifecore Biomedical – participating (1-on-1s and meetings).

0 · Reply

11thestate Jan. 6 at 2:41 PM

Don't forget that there is also an important settlement to watch for $LFCR We have every detail, including how investors can get paid: https://11th.com/cases/lifecore-investor-settlement

0 · Reply

PrecisionChartist Dec. 27 at 6:14 AM

$LFCR Sentiment increasingly tracks operational truth rather than guidance tone. Governance alignment can reduce perceived uncertainty. Execution consistency is the fastest path to confidence rebuilding. Execution quality becomes the defining catalyst from here.

0 · Reply

11thestate Dec. 23 at 2:58 PM

$LFCR investors, if you follow us, you already know about it. This info hits different after the news. Check it out: https://11th.com/cases/lifecore-investor-settlement

0 · Reply

BearTamerTrading Dec. 18 at 4:07 PM

📈 Market Alerts — Bear Tamer Trading Part 2 of 2 - 12/17/22 🔥 $AMCI — AMC Robotics Volatile mover during the session — reminder why risk management is always priority. 🔥 $LFCR — Lifecore Biomedical Strong intraday action with buyers stepping in and price holding key levels. 🔥 $PCSA — Processa Pharmaceuticals High-risk, high-reward biotech with sharp moves that required discipline. 🔥 $TGL — Treasure Global Choppy but tradable action during market hours, stayed active into the close. 🔥 $UDMY — Udemy Held steady throughout the session, remained on radar as a potential continuation setup. Congrats again to everyone who stayed locked in during Market Alerts 💰👏 Proof of live coverage here ⬇️ 🔗 https://www.youtube.com/live/AfPLYIui4Lw?si=xQ950lEw771yVB7A

2 · Reply

DARKP00L Dec. 18 at 12:10 PM

$LFCR 07:03 on Dec. 18 2025 Lifecore Biomedical To Join Nasdaq Biotechnology Index Effective Before Market Open December 22, 2025 #tradeideas

0 · Reply

DARKP00L Dec. 17 at 5:37 PM

$LFCR 12:12 on Dec. 17 2025 Lifecore Biomedical shares are trading higher after the company announced that it has signed a CDMO master services agreement with a global pharmaceutical customer. #tradeideas

0 · Reply

SuperGreenToday Dec. 16 at 1:22 PM

$LFCR Share Price: $7.89 Contract Selected: Jun 18, 2026 $10 Calls Buy Zone: $0.42 – $0.53 Target Zone: $0.74 – $0.91 Potential Upside: 65% ROI Time to Expiration: 183 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

11thestate Dec. 11 at 3:24 PM

$LFCR has reached a settlement with investors over claims that it issued inaccurate financial statements due to weak internal controls and overstated its financial position. Who’s eligible? Anyone who purchased $LFCR shares between October 7, 2020 and March 19, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? Payout per share not determined yet. Can I still file? Yes — claims are currently being accepted under a tentative settlement. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/lifecore-investor-settlement

0 · Reply

HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Jan 16, 2026, 4:45 PM EST - 18 days ago

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jan 15, 2026, 10:39 AM EST - 19 days ago

Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Jan 1, 2026, 8:50 AM EST - 4 weeks ago

Lifecore Biomedical: The Turnaround Is Just Getting Started

Dec 18, 2025, 7:00 AM EST - 6 weeks ago

Lifecore Biomedical to be Added to Nasdaq Biotech Index

Dec 17, 2025, 7:00 AM EST - 7 weeks ago

Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer

Dec 16, 2025, 7:00 AM EST - 7 weeks ago

Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference

Nov 11, 2025, 4:05 PM EST - 3 months ago

Lifecore Biomedical to Participate in Upcoming Investor Conferences

Nov 6, 2025, 8:56 PM EST - 3 months ago

Lifecore Biomedical, Inc. (LFCR) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 3 months ago

Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update

Oct 30, 2025, 4:05 PM EDT - 3 months ago

Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025

Oct 29, 2025, 7:00 AM EDT - 3 months ago

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

Oct 28, 2025, 7:00 AM EDT - 3 months ago

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

Oct 13, 2025, 7:00 AM EDT - 4 months ago

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

Sep 23, 2025, 4:30 PM EDT - 4 months ago

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Sep 9, 2025, 7:07 PM EDT - 5 months ago

Lifecore Biomedical, Inc. (LFCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 4, 2025, 4:05 PM EDT - 5 months ago

Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

Aug 8, 2025, 9:16 AM EDT - 6 months ago

Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 6 months ago

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update

Aug 7, 2025, 4:45 AM EDT - 6 months ago

Laughing Water Capital's Top 5 Positions For Q2 2025

Jul 31, 2025, 4:05 PM EDT - 6 months ago

Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025

Jul 8, 2025, 9:00 AM EDT - 7 months ago

Stock Picks From Seeking Alpha's June 2025 New Analysts

AENT AHCO APP ASGN ASML ASTS CRCL

Jun 18, 2025, 3:27 AM EDT - 8 months ago

Lifecore Biomedical: Inflecting Financials Over Next 3 Years

Jun 17, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect

Jun 17, 2025, 7:00 AM EDT - 8 months ago

Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer

Jun 15, 2025, 10:00 AM EDT - 8 months ago

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jun 12, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation

Jun 12, 2025, 7:00 AM EDT - 8 months ago

Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale

Jun 10, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation

Jun 8, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out

Jun 5, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 8 months ago

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation

May 29, 2025, 10:05 AM EDT - 8 months ago

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 27, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect

May 27, 2025, 7:00 AM EDT - 9 months ago

Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

May 25, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation

May 22, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation

May 19, 2025, 9:35 AM EDT - 9 months ago

Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings

BUR CLBT KKR PAR

May 11, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out

May 8, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out

Apr 29, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect

Apr 24, 2025, 11:30 AM EDT - 10 months ago

Laughing Water Capital Top 5 Investments (Q1 2025)

ARR NN PAR PLYA

Apr 22, 2025, 7:00 AM EDT - 10 months ago

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

Apr 14, 2025, 7:00 AM EDT - 10 months ago

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer

Apr 3, 2025, 4:05 PM EDT - 10 months ago

Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update

Mar 27, 2025, 4:05 PM EDT - 11 months ago

Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025

Mar 17, 2025, 7:00 AM EDT - 11 months ago

Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome

11thestate Jan. 16 at 2:42 PM

0 · Reply

BearTamerTrading Jan. 11 at 11:57 PM

0 · Reply

11thestate Jan. 6 at 2:41 PM

Don't forget that there is also an important settlement to watch for $LFCR We have every detail, including how investors can get paid: https://11th.com/cases/lifecore-investor-settlement

0 · Reply

PrecisionChartist Dec. 27 at 6:14 AM

0 · Reply

11thestate Dec. 23 at 2:58 PM

$LFCR investors, if you follow us, you already know about it. This info hits different after the news. Check it out: https://11th.com/cases/lifecore-investor-settlement

0 · Reply

BearTamerTrading Dec. 18 at 4:07 PM

2 · Reply

DARKP00L Dec. 18 at 12:10 PM

$LFCR 07:03 on Dec. 18 2025 Lifecore Biomedical To Join Nasdaq Biotechnology Index Effective Before Market Open December 22, 2025 #tradeideas

0 · Reply

DARKP00L Dec. 17 at 5:37 PM

0 · Reply

SuperGreenToday Dec. 16 at 1:22 PM

0 · Reply

11thestate Dec. 11 at 3:24 PM

0 · Reply

JarvisFlow Dec. 8 at 2:37 PM

Stephens & Co. has updated their rating for Lifecore Biomedical ( $LFCR ) to Equal-Weight with a price target of 6.

0 · Reply

11thestate Nov. 26 at 3:34 PM

Don't forget that there is also an important settlement to watch for $LFCR. We have every detail, including how investors can get paid. #LFCR #LifecoreBiomedical https://11th.com/cases/lifecore-investor-settlement

0 · Reply

WeFindBitcoin Nov. 25 at 6:27 PM

$LFCR super low flat, this is my safe harbor in the storm. holding this i'm not worry about anything.

0 · Reply

Doozio Nov. 23 at 5:02 PM

$LFCR chop chop huckleberries rotation and all that $JAZZ 🐒🍌🧠⏰♾️

0 · Reply

WeFindBitcoin Nov. 14 at 8:12 PM

$LFCR we will see 10 in the upcoming weeks, i will trim at 10, i'm not selling a single share before 10.

0 · Reply

WeFindBitcoin Nov. 12 at 12:21 AM

$LFCR easy 20% gain already, we will see 20

1 · Reply

DARKP00L Oct. 29 at 11:31 AM

$LFCR 07:23 on Oct. 29 2025 Lifecore Expands CDMO Business, Becomes Supplier Of Choice For Leading Injectable Drug #tradeideas

0 · Reply

DARKP00L Oct. 29 at 11:26 AM

$LFCR 07:23 on Oct. 29 2025 Lifecore Expands CDMO Business, Becomes Supplier Of Choice For Leading Injectable Drug #tradeideas

0 · Reply

WeFindBitcoin Oct. 22 at 2:23 PM

$LFCR my low-beta play, just hold it for 2 years, easy 3 times investment. big onshore GPL-1 manufacturer

0 · Reply

Market Cap	325.58M
Revenue (ttm)	128.87M
Net Income (ttm)	-38.72M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-30.05%
Debt to Equity Ratio	4.36

Volume	137,700
Avg Vol	151,004
Day's Range	N/A - N/A
Shares Out	37.47M
Stochastic %K	11%
Beta	0.59
Analysts	Sell
Price Target	$9.25